<?xml-stylesheet type="text/xsl" href="varreports_v3.xsl"?><data_table name="TOPMed_WGS_GOLDN_Sample_Attributes" dataset_id="pht008690.v1" study_name="NHLBI TOPMed: Genetics of Lipid Lowering Drugs and Diet Network (GOLDN)" study_id="phs001359.v2" participant_set="1" date_created="2019/12/11"><description>This sample attributes table includes body site where sample was collected, analyte type, tumor status, sequencing center, funding source, TOPMed phase, project, and study name.</description><variable id="phv00400278.v1.p1" var_name="SAMPLE_ID" calculated_type="string" reported_type="string"><description>De-identified Sample ID</description><total><subject_profile><sex><male>505</male><female>558</female></sex></subject_profile><stats><stat n="1064" nulls="0"/></stats></total></variable><variable id="phv00400279.v1.p1" var_name="BODY_SITE" calculated_type="string" reported_type="string"><description>Body site where sample was collected</description><total><subject_profile><sex><male>505</male><female>558</female></sex></subject_profile><stats><stat n="1064" nulls="0"/><enum count="1064">Blood</enum></stats></total></variable><variable id="phv00400280.v1.p1" var_name="ANALYTE_TYPE" calculated_type="string" reported_type="string"><description>Analyte Type</description><total><subject_profile><sex><male>505</male><female>558</female></sex></subject_profile><stats><stat n="1064" nulls="0"/><enum count="1064">DNA</enum></stats></total></variable><variable id="phv00400281.v1.p1" var_name="IS_TUMOR" calculated_type="string" reported_type="string"><description>Whether or not sample came from a tumor tissue</description><total><subject_profile><sex><male>505</male><female>558</female></sex></subject_profile><stats><stat n="1064" nulls="0"/><enum count="1064">No</enum></stats></total></variable><variable id="phv00400282.v1.p1" var_name="SEQUENCING_CENTER" calculated_type="string" reported_type="string"><description>Name of the center which conducted sequencing</description><total><subject_profile><sex><male>505</male><female>558</female></sex></subject_profile><stats><stat n="1064" nulls="0"/><enum count="1064">UW</enum></stats></total></variable><variable id="phv00400283.v1.p1" var_name="Funding_Source" calculated_type="string" reported_type="string"><description>Project funding source</description><total><subject_profile><sex><male>505</male><female>558</female></sex></subject_profile><stats><stat n="1064" nulls="0"/><enum count="1064">TOPMed</enum></stats></total></variable><variable id="phv00400284.v1.p1" var_name="TOPMed_Phase" calculated_type="integer" reported_type="integer"><description>TOPMed Phase</description><total><subject_profile><sex><male>505</male><female>558</female></sex></subject_profile><stats><stat n="1064" nulls="0" mean="2" sd="0" median="2" min="2" max="2"/><enum count="1064">2</enum></stats></total></variable><variable id="phv00400285.v1.p1" var_name="Study_Name" calculated_type="string" reported_type="string"><description>TOPMed Project that funded sequencing</description><total><subject_profile><sex><male>505</male><female>558</female></sex></subject_profile><stats><stat n="1064" nulls="0"/><enum count="1064">GOLDN</enum></stats></total></variable><variable id="phv00400286.v1.p1" var_name="TOPMed_Project" calculated_type="string" reported_type="string"><description>TOPMed-assigned short study name (1:1 with TOPMed phs number)</description><total><subject_profile><sex><male>505</male><female>558</female></sex></subject_profile><stats><stat n="1064" nulls="0"/><enum count="1064">GOLDN</enum></stats></total></variable></data_table>
